K. M. Venkat Narayan, MD, MSC, MBA, FRCP, is the Ruth and O.C. Hubert Professor of Global Health and Epidemiology at Rollins School of Public Health and a professor of medicine and endocrinology at Emory University School of Medicine. Dr. Narayan serves as executive director of the Emory Global Diabetes Research Center.
A leading international diabetes expert, he is noted for substantial multidisciplinary work in diabetes and noncommunicable diseases epidemiology, pathophysiology, translation research and public health.
Titles & Roles
Ruth and O.C. Hubert Professor of Global Health and Epidemiology
Rollins School of Public Health, Emory University
Professor of Medicine and Endocrinology
Emory University School of Medicine
Executive Director
Emory Global Diabetes Research Center
Professional Memberships
Dr. Narayan is an elected member of the US National Academy of Medicine and a foreign fellow of the Indian National Science Academy. He serves on the Committee of the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine.
Research
Dr. Narayan has been involved in several major national and international multi-center epidemiological studies, randomized controlled trials, public health surveillance, translation research and health policy studies. His seminal scientific contributions include advancing diabetes prevention trials, conceptualizing and advancing diabetes translation research, systematic documentation of type 2 diabetes in youth and raising it as a public health problem, the world’s first assessment of lifetime risk of diabetes, models of projection of diabetes burdens, the first paper on national incidence of childhood obesity, and lately highlighting insulin-deficient phenotypes of type 2 diabetes. He is currently also exploring pancreatic beta cell biology and intriguing differences in the pathophysiology of type 2 diabetes in Asian, African, Native American and developing countries’ populations globally.
Publications
With more than 570 publications, including several high-impact studies, and over 210,000 citations, his work exemplifies his global leadership and influence in diabetes and noncommunicable science and public health.
